Partnerships for Research in Implementation Science for Equity in Heart and Lung diseases training program (PRISE-HL T32)

心肺疾病公平实施科学研究伙伴关系培训计划 (PRISE-HL T32)

• 批准号: 10553831
• 负责人: Adithya Cattamanchi
• 金额: $ 46.86万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-07-01 至 2028-06-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10553831
• 关键词: Equity; Heart Diseases; Lung diseases; Research; Training Programs; implementation science

Summary Implementation science (ImS) is a branch of research that focuses on the improving the uptake of evidence- based health interventions into real world settings. ImS holds promise for generating new knowledge to close the gap between what we know can optimize health and healthcare and what happens in everyday practice, which may be of particular importance for addressing health inequities that often result because of failure to deliver evidence-based practice to all populations. The goal of the Partnerships for Research in Implementation Science for Equity in Heart and Lung (PRISE-HL) diseases T32 program is to provide support to outstanding scientists equipped to build on their scholarship with interdisciplinary training in implementation science and health equity approaches to help transform the uptake and delivery of evidence-based interventions for heart and lung diseases in real-world settings. UCSF is one of the world’s leading health sciences campuses and this program will build on existing strengths in heart and lung diseases research as well as infrastructure established through the recently launched UCSF PRISE Center, an innovative research center bringing together ImS researchers with front-line implementers in local health systems and public health departments. A physician- scientist and public health trained epidemiologist, both with extensive experience in applying implementation science to health equity and who are leaders in ImS training, will direct the program. An exceptionally accomplished group of faculty with strong records of interdisciplinary collaboration will bring complementary expertise in clinical and translational research related to heart and lung diseases and key health equity and/or implementation science-relevant disciplines, including behavior change, community engagement, health economics, health policy, big data, and sociology. In addition, the program includes strong partnerships with community and tertiary care clinical sites that serve the diverse communities of the San Francisco Bay Area and with local (San Francisco) and regional (California) Departments of Public Health. An Advisory Committee will work with the program directors to select T32 trainees, monitor trainees’ progress, and identify opportunities for improving the program. The trainee recruitment process will benefit from access to a large and diverse pool of internal candidates from UCSF’s well-established training programs and provide additional opportunities for us to continue to recruit the most promising external trainees. Each trainee will work with mentors on their career development committee to establish goals and tailor didactic and hands-on training experiences to develop competencies in core areas of implementation science and health equity research. Trainees will also benefit from embedded healthcare delivery system or public health program rotations to develop experience with real-world practice change and a new PRISE-HL T32 Program Seminar that will integrate training in implementation science and health equity research.

总结